O-8 Somatic and germline heterogeneity across colorectal cancer patient characteristics: Implications for early cancer detection
Year: 2023
Type: article
Study design: Observational Study
Source: Annals of Oncology
Authors: J. Weitzel, P. Srinivasan, B. Gutman, S. Bristow, H. Wu, R. Salari, R. Swenerton, T. Kawli, A. Aleshin, M. Rabinowitz, B. Zimmermann, B. Mitchell, J. Reiter
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, American Society of Clinical Oncology, Celgene, F. Hoffmann-La Roche, Array BioPharma, Merck KGaA, Taiho Pharmaceutical, Les Laboratories Pierre Fabre, Halozyme, Mylan, Mirati Therapeutics, BeiGene, Incyte, Advanced Accelerator Applications, Kaken Pharmaceutical, Seagen, Cancer Research UK, Daiichi-Sankyo, Astellas Pharma, Shionogi, European Society for Medical Oncology, Otsuka Pharmaceutical, Sociedad Española de Oncología Médica, Servier, Novartis Farmacéutica, Ono Pharmaceutical, Ipsen, Sirtex Medical, LEO Pharma, Genentech, Samsung, Chugai Pharmaceutical, MSD K.K., Daiichi Sankyo Europe, Cilag
OpenAlex ID: W4382811428